Name | RWJ 63556 |
---|---|
Synonyms |
Methanesulfonamide, N-[5-(4-fluorophenoxy)-2-thienyl]-
N-[5-(4-Fluorophenoxy)-2-thienyl]methanesulfonamide |
Description | RWJ 63556 is an orally active COX-2 selective/5-lipoxygenase inhibitor, with anti-inflammatory activities. |
---|---|
Related Catalog | |
Target |
COX-2 5-Lipoxygenase |
In Vitro | RWJ 63556 is a potent inhibitor of leukocyte influx over a period of 24 hr and maintains its in vitro profile on eicosanoids[1]. |
In Vivo | RWJ 63556 (1 mg/kg, i.v.) significantly inhibits the development of SP-induced oedema[2]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 403.4±55.0 °C at 760 mmHg |
Molecular Formula | C11H10FNO3S2 |
Molecular Weight | 287.330 |
Flash Point | 197.8±31.5 °C |
Exact Mass | 287.008606 |
LogP | 4.22 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.624 |
Storage condition | 2-8℃ |